BPC-157 vs GHK-Cu

Repair peptide versus copper tripeptide. Here is how the two research peptides compare on class, format and price.

BPC-157

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a protein found in gastric juice. It is supplied as a lyophilised (freeze-dried) powder in a 10 mg vial for laboratory and in-vitro research use only.

In published research models BPC-157 is studied for its interaction with angiogenic and growth-factor signalling, and for its effects on connective-tissue and gastrointestinal repair pathways. It is frequently paired with TB-500 in comparative research.

GHK-Cu

GHK-Cu (copper tripeptide-1) is a naturally occurring copper-binding tripeptide, supplied lyophilised in 50 mg and 100 mg vials for laboratory and in-vitro research use only.

GHK-Cu is studied for its role in copper transport, collagen and extracellular-matrix remodelling, and skin-related research models. It is a component of the GLOW and KGLOW research blends.

Which do researchers choose?

BPC-157 and GHK-Cu are repair peptide versus copper tripeptide. The right choice depends on the research question: they differ in class (Pentadecapeptide (Body Protection Compound-157) vs Copper tripeptide-1) and strength (10 mg vs 50 / 100 mg). Both are supplied lyophilised, third-party HPLC tested, and shipped express post Australia-wide for laboratory and in-vitro research use only.

Frequently asked questions